Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually
Author:
Affiliation:
1. Calvary Mater Newcastle, Newcastle, NSW.
2. Hunter Medical Research Institute Newcastle, NSW.
3. Mater Hospital, Sydney, NSW.
Publisher
Wiley
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja14.01202
Reference6 articles.
1. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
2. Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program
3. Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors
4. Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience;Frontiers in Oncology;2023-04-14
2. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis;Applied Health Economics and Health Policy;2017-07-29
3. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years;Value in Health;2017-04
4. Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes;British Journal of Clinical Pharmacology;2015-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3